Background and Purpose-Endovascular thrombectomy is an increasingly used treatment for arterial occlusion in acute stroke. Various devices (including most extensively the Mechanical Embolus Removal in Cerebral Ischemia [MERCI] Retriever device) have been used for this. Methods-We review the neuropathologic findings in 5 patients (age range, 59 to 87 years) who died acutely or as late as 38 days after procedures using the MERCI (4 patients) and Penumbra (1 patient) devices were carried out to remove thromboemboli from the middle cerebral artery. Partial recanalization was achieved by thrombectomy in all 5 patients. Results-All patients showed extensive cerebral infarcts, 3 of 5 with clinical hemorrhagic transformations of the infarct or frank intraparenchymal hemorrhage after thrombectomy; in 1 case, this was judged to be at least partly on the basis of concomitant hypertensive microvascular disease. With 1 exception, basal arteries examined in detail by immunohistochemistry showed prominent, although usually nonocclusive (and generally nonulcerated), atheromata, often with significant luminal stenosis. One patient showed a subintimal dissection with resultant occlusion of the middle cerebral artery. Conclusions-In this highly selected group of patients, the vascular pathological abnormalities affecting basal arteries were variable, but complicated atherosclerosis was a common finding. Extensive irreversible brain necrosis before therapeutic procedures may have contributed to deaths. (Stroke. 2010;41:938-947.)
ndovascular thrombectomy procedures are frequently performed to extract thromboemboli that have occluded major branches of the circle of Willis and proximal arteries emerging from it. [1] [2] [3] [4] [5] [6] [7] The design, preclinical testing, and practical uses of various devices used to carry out the procedure have been described in several publications as have treatment outcomes. 8 -15 The retrieved thromboemboli have been carefully studied for their cellular and biochemical components with the hope that the results of such studies may shed light on why thromboembolectomy is effective in only some patients. 16 Autopsy findings have not previously been described in patients who have undergone thrombectomy. Analysis of outcomes after thrombectomy shows that mortality is substantial in both those in whom recanalization of an occluded artery has been achieved (mortality rates of 20% to 40%) and those in whom recanalization is not achieved (60% to 80%). 10 Patients who undergo autopsy (after any therapeutic procedure) clearly represent a highly selected population with the worst possible outcome. We undertook this study to investigate vascular and brain parenchymal abnormalities in 5 patients who died after thrombectomy.
Subjects and Methods
Subjects included in the study were 5 individuals (4 females, 1 male with an age range of 59 to 87 years; mean age, 75.6 years) who died and underwent autopsy after thrombectomy after acute stroke. The indication for thrombectomy was to restore blood flow to the neurovasculature by removing thrombus. The attending physician used his judgment to offer the treatment option with the greatest potential for a beneficial outcome.
The Mechanical Embolus Removal in Cerebral Ischemia (MERCI) Retriever device had been used in 4 individuals, whereas the fifth patient was treated with a Penumbra device. their presenting stroke are provided in the Table. All individuals had presented with a large left or right cerebral hemispheric (MCA territory) infarct; 3 were thought to have originated from a cardiogenic embolus, 1 from in situ thrombosis in the right MCA, and in our most recently encountered patient, there was significant atherosclerosis of the cerebral arteries as well as multiple potential sources of cardiogenic emboli. The most recently studied individual had developed symptoms during an airplane flight, necessitating an emergency landing and transfer to the hospital. Presenting symptoms and medications patients were receiving are listed. All subjects had undergone thrombectomy with heparin flush (5000 u/L) delivered through the guide catheter during the procedure after having experienced their "stroke." Groin puncture was median 5 hours 10 minutes after the last known well time (range 1 hour 15 minutes to 7 hours 15 minutes).
End-of-procedure Thrombolysis in Cerebral Infarction score was 2 in all patients. 17 Patients survived over a range of 1 to 38 days after thrombectomy. One patient (Patient 3, the longest postthrombectomy survivor in this series) had undergone hemicraniectomy 12 days after the stroke to relieve rising intracranial pressure.
In all autopsies, brains were removed and processed using conventional techniques. Complete autopsy was carried out on 4 of the 5 patients. Before sectioning of each brain, the circle of Willis and its major branches were dissected from its base and cross-sectioned. Multiple segments from major branches of the circle of Willis were studied by routine histology and/or immunohistochemistry (see subsequently). Digital images of fixed brain slices were retained.
Routine paraffin sections of arteries from all cases were stained with hematoxylin and eosin as well as the elastica van Gieson (EVG) method (Diagnostic Biosystems, Pleasanton, Calif) to highlight elastica and intimal thickening. Immunoperoxidase immunohistochemistry was performed on sections from selected blocks using primary antibodies to smooth muscle actin (SMA, to show smooth muscle cells) and CD68 (to demonstrate macrophages). Primary antibodies for these studies were from Dako (Carpinteria, Calif) and used at a primary dilution of 1:100 (both SMA and CD68). Digital photographs of EVG-stained arteries were subject to the computer programs Adobe Photoshop CS2 Version 9.0 and Image J 1.38X allowing for quantification of percentage stenosis of atherosclerotic segments.
Results
Clinicopathologic features for all patients are summarized in the Table. Figures representing radiographic and neuropathologic findings are intentionally presented sequentially from the earliest patient encountered to the most recent using the numbering system given in the Table. The atheromatous plaque in all examined arteries showed varying collections of SMA-immunoreactive smooth muscle cells and CD68-immunoreactive macrophages, smooth muscle cells often forming a subintimal cap over collections of macrophages. None showed ulceration of the plaque or intraplaque hemorrhage (Figures 1, 3, 6 , 8C-E, and 11). Lumina of MCA segments examined from Patients 2, 4, and 5 were patent. Atheroemboli were not found in the distal circulation of any case, although rare small arteries showed occlusion by platelet-fibrin thromboemboli. The estimated degree of arterial stenosis varied from virtually none to 75%, mean 45%. (Figure 1 ). This dissection occurred over a comparatively nonatherosclerotic portion of that artery. Arterial segments from 4 of the 5 patients (the exception being Patient 3) showed significant complicated atherosclerosis with varying degrees of atherosclerotic stenosis of arterial segments that had been traversed during thrombectomy.
All brains examined showed hemispheric infarcts, which were consistent in appearance (grossly and microscopically) with the clinical onset of stroke symptoms and corresponding neuroimaging studies (Figures 2, 4 , 5, and 7 through 10). In Patients 1, 2, and 4, the infarcts were associated with massive, fatal cerebral edema. In Patient 3 (who survived the procedure by Ͼ1 month), edema had subsided and the right cerebral hemispheric infarct showed cystic cavitation. In Patient 5, an extensive, substantially hemorrhagic cortical infarct was noted in the left cerebral hemisphere (Figure 10) , whereas an acute hematoma in the left basal ganglia was attributed to significant hypertensive arteriopathy.
Major general autopsy findings included the following: Patient 1 had neurogenic pulmonary edema and pleural effusions; Patient 3 had moderate coronary artery atherosclerosis, evidence of ischemic cardiomyopathy with a left ventricular aneurysm, and diffuse alveolar damage; Patient 4 had coronary artery disease with past stenting of several arteries and atherosclerosis of the abdominal aorta; Patient 5 had severe generalized and coronary atherosclerosis with ischemic changes in the myocardium, a history of bioprosthetic aortic valve replacement, and cardiomegaly with left ventricular and biatrial dilatation. The cerebral abnormalities, especially infarct with edema and/or cerebral hemorrhage, 
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were deemed major factors contributing to death in all cases, but especially in 3 individuals.
Discussion
To our knowledge, this is the first report describing the vascular and neuropathologic abnormalities in a group of patients who died after endovascular thrombectomy procedures, all carried out to extract thromboemboli from MCA segments. The authors recognize that this small series represents a highly select group of patients who contrast in striking terms with the numerous patients who have received benefit from innovative thromboembolectomy procedures. [1] [2] [3] [4] [5] [6] [7] [8] [9] [10] [11] [12] [13] [14] [15] In a large multicenter trial of 164 patients who underwent thrombectomy within 8 hours of stroke symptom onset, 57.3% of treated patients showed successful recanalization in "treatable" arteries and 69.5% recanalized vessels after adjunctive therapy. 18 Favorable clinical outcomes were observed in 36% with an overall mortality rate of 34%. Outcome may to some extent be dependent on the nature of the material occluding an affected artery, a detailed morphological analysis of which has previously been published. 16 Further detailed analysis may well shed light on molecular components within a thromboembolus that render a patient more or less likely to have a good outcome. Systemic disease, usually complications of atherosclerosis involving the coronary and other arteries (including the aorta) and pulmonary lesions, almost certainly contributed to death in all patients. In at least 3 of 5 patients, large MCA territory infarcts with associated mass effect from edema were judged to have significantly contributed to fatal outcomes. In every case, microscopic features of cerebral infarcts were consistent with their having occurred at the time of symptom onset. These 5 patients did not survive their strokes; 3 developed hemorrhages after the procedure. Patient 2 had a small subarachnoid hemorrhage, likely caused by the procedure. Patient 4 had a large hemorrhage. In Patients 4 and 5, significant parenchymal hemorrhage was superimposed on ischemic lesions in the same cerebral hemisphere. In Patient 4, the parenchymal hemorrhage had extended into the lateral ventricle, parenchymal hematomas Berger Type 2 and a subarachnoid hemorrhage, due to the tissue plasminogen activator, 19 whereas Patient 5 developed a hemorrhagic infarct Type 1, unlikely due to the procedure. The ganglionic hematoma observed in this patient was deemed in part to be on the basis of concomitant hypertensive cerebral microvascular disease. The first patient in our series had experienced a subintimal arterial dissection in a severely atherosclerotic segment of her MCA, 20 although the dissection occurred in a portion of the arterial wall that did not show significant atheroma. The immediate causes of death for Patients 1 and 5 were the families' decisions to withdraw care. All care was withdrawn except for the ventilator for Patient 3, and comfort care protocols were initiated for the remaining patients.
In addition to the 1 patient who appeared to have a procedure-related MCA dissection, 1 other (the longest survivor among the 5) showed complete occlusion of the MCA segment with advanced organization of the thromboembolus, consistent with its having developed at or around the time of the presenting stroke and the endovascular procedure. Other arterial segments examined in detail (from Patients 1, 2, 4, and 5) showed variably advanced, usually complicated atheromata (confirmed by immunohistochemistry) with stenosis, although no evidence of acute intraplaque hemorrhage or intimal ulceration. 21 The lumens in such vessels were patent. Atheroemboli, sometimes encountered in the distal arteries of patients with severe atherosclerosis in the cervical arteries, were not found in any of these patients despite extensive sampling of brain parenchyma. The presence of substantial intracranial atherosclerosis in these cases has important implications for patient selection and further device development. Thrombectomy devices are designed to retrieve or aspirate thrombi from relatively normal arterial beds rather than severely atherosclerotic arteries. The loops of the MERCI Retriever can snag and unwind on fixed atheroma with risk of impaired thrombus removal, local vessel dissection, and remote vessel traction injury. 22 The Penumbra system is too large and bulky to pass easily through stenotic atherosclerotic segments, limiting its ability to aspirate more distally located thrombi. When the target occlusive lesion is known to consist substantially of in situ atherosclerosis, primary angioplasty and stenting-cracking, stretching, and maintaining radial force on the plaque-could be a treatment option rather than embolectomy. 23 In the 5 cases in this series, the interventional team believed at the time of treatment that the vascular occlusions were largely thrombi with only minimal in situ atherosclerosis. All patients had normal neck arteries according to angiography. Patients 2, 4, and 5 had atrial fibrillation and came in with a normal international normalized ratio, leading to the presumption that the source of the clots was cardiac. Patient 5 also had a heart valve replacement, increasing the likelihood of a cardiac embolus. A workup for Patient 1 was not done due to the severity of the patient's stroke, but she had a history of severe ischemic heart disease and previous myocardial infarctions, indicating that the source of clot was presumably cardiac. Patient 3 had ischemic cardiomyopathy with congestive heart failure; her stroke was likely caused by a cardiogenic embolus. The untoward outcome in these 4 cases that actually harbored moderate or extensive local atherosclerosis highlights the need for improved methods to diagnose target occlusion composition pretreatment such as making intravascular ultrasound catheter tips small and navigable enough for deployment in the intracranial circulation. 
